#1 Clinical Trials Search in Europe

Clindamycin

This article examines the use of clindamycin, an antibiotic, in various clinical trials. Clindamycin has been studied for its effectiveness in treating conditions such as bacterial vaginosis, acne, septic abortion, and preventing preterm birth. The trials explore different dosages, administration methods, and combinations with other treatments to determine the optimal use of clindamycin in various medical scenarios.

Table of Contents

What is Clindamycin?

Clindamycin is an antibiotic medication used to treat various bacterial infections. It belongs to a class of drugs called lincosamides. Clindamycin works by stopping the growth of bacteria, helping your body’s immune system fight off the infection[1].

This antibiotic is known by several brand names, including:

  • Dalacin (as Dalacin C or Dalacin vaginal cream)
  • Cleocin
  • Clindoxyl (when combined with benzoyl peroxide)

Uses of Clindamycin

Clindamycin is prescribed to treat a wide range of bacterial infections, including:

  • Osteoarticular infections: These are infections affecting bones and joints. Clindamycin is effective against Staphylococcus aureus, a common cause of these infections[1].
  • Acne: Clindamycin is often used in combination with other medications to treat moderate to severe acne[2].
  • Bacterial vaginosis: This is an imbalance of bacteria in the vagina that can cause unpleasant symptoms. Clindamycin is one of the treatments used for this condition[3][4].
  • Septic abortion: This is a serious infection of the uterus following an abortion. Clindamycin, often combined with other antibiotics, is used to treat this condition[5].
  • Prosthetic joint infections: Clindamycin can be used to treat infections in artificial joints, particularly hip prostheses[6].

Forms and Administration

Clindamycin comes in several forms, depending on the condition being treated:

  • Oral capsules or tablets: These are typically taken by mouth, often two to four times a day[5].
  • Intravenous (IV) solution: For severe infections, clindamycin may be given directly into a vein[7].
  • Topical gel or cream: Used for acne treatment, applied directly to the skin[8].
  • Vaginal cream: Used for treating bacterial vaginosis[3].

The dosage and duration of treatment can vary widely depending on the type and severity of the infection, as well as the patient’s age and weight. Always follow your healthcare provider’s instructions carefully.

Effectiveness

Clindamycin has been shown to be effective in treating various bacterial infections. Here are some key points about its effectiveness:

  • In osteoarticular infections, clindamycin is considered a good option due to its action against biofilm formation (a layer of bacteria that sticks to surfaces) and its high level of penetration into bones and joints[1].
  • For acne treatment, studies have shown that combinations of clindamycin with other medications (like adapalene or benzoyl peroxide) can significantly reduce acne lesions[2][8].
  • In bacterial vaginosis, clindamycin has shown high cure rates, although more research is needed to determine its effectiveness in preventing preterm birth in pregnant women with this condition[3][9].
  • For septic abortion, clindamycin combined with gentamicin has shown high cure rates, even when administered once daily instead of three times a day[5].

Side Effects and Safety

Like all medications, clindamycin can cause side effects. Common side effects may include:

  • Nausea or vomiting
  • Diarrhea
  • Skin rash
  • When used topically for acne: redness, dryness, or itching of the skin[8]

In rare cases, clindamycin can cause more serious side effects, including severe diarrhea caused by a type of bacteria called Clostridioides difficile. If you experience severe or persistent diarrhea during or after treatment with clindamycin, contact your healthcare provider immediately.

It’s important to inform your doctor about any allergies you have, especially to lincomycin, as it’s related to clindamycin. Also, tell your doctor about all medications you’re taking, as clindamycin can interact with certain drugs[1].

Ongoing Research

Researchers continue to study clindamycin to understand its effectiveness in various conditions and to optimize its use. Some areas of ongoing research include:

  • Investigating the optimal dosing of clindamycin for different infections, including studies on once-daily dosing versus multiple daily doses[5].
  • Studying the effectiveness of clindamycin in preventing preterm birth in pregnant women with bacterial vaginosis[9].
  • Exploring how obesity affects the way the body processes clindamycin, which could impact dosing recommendations for overweight or obese patients[7].
  • Investigating new combinations of clindamycin with other antibiotics or medications for various infections[6].

These ongoing studies aim to improve our understanding of clindamycin and optimize its use in treating various bacterial infections.

Condition Clindamycin Use Key Findings/Objectives
Acne Combined with adapalene in gel form Evaluating safety and efficacy of different concentrations
Bacterial Vaginosis Oral and vaginal administration Assessing cure rates and prevention of preterm birth
Septic Abortion Intravenous administration Comparing once-daily vs. thrice-daily dosing for clinical improvement
Preterm Birth Prevention Oral administration Testing efficacy in reducing preterm delivery rates
Pediatric Infections Intravenous and oral administration Studying pharmacokinetics in overweight and obese children
IVF Outcomes Oral administration with live biotherapeutic Evaluating impact on clinical pregnancy rates and vaginal microbiota

FAQ

  • What conditions is clindamycin being studied for in these clinical trials? Clindamycin is being studied for various conditions including acne, bacterial vaginosis, septic abortion, prevention of preterm birth, and as a treatment for abnormal vaginal microbiota in IVF patients.
  • How is clindamycin administered in these trials? Clindamycin is administered in various ways depending on the trial, including oral capsules, intravenous infusions, vaginal creams, and as part of combination treatments with other medications.
  • What are some of the potential benefits of clindamycin treatment being studied? Potential benefits being studied include reducing acne lesions, preventing preterm birth, treating septic abortion, curing abnormal vaginal microbiota, and improving reproductive outcomes in IVF patients.
  • Are there any side effects of clindamycin mentioned in these trials? While specific side effects are not detailed in the trial summaries provided, the studies are designed to assess both the efficacy and safety of clindamycin treatments. Some trials mention monitoring for complications or adverse events.
  • How long do the clindamycin treatments typically last in these trials? Treatment duration varies widely depending on the condition and trial design. Some treatments last for a few days (e.g., 5-7 days), while others may continue for several weeks or until a specific clinical outcome is achieved.

Ongoing Clinical Trials on Clindamycin

  • Study of Clindamycin Use During Heart Surgery with Extracorporeal Circulation to Prevent Surgical Site Infections

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Study on Using Gentamicin and Clindamycin to Prevent Abscesses After Surgery for Complicated Appendicitis in Patients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Effectiveness of Clarithromycin and Other Drug Combinations for Patients with Uncomplicated Staphylococcus aureus Blood Infection

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study on Antibiotic Levels in Blood of Pregnant Women with Twins Using Piperacillin, Tazobactam, Cefazolin, Ampicillin Sodium, and Clindamycin

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria

  • Study on Preventing Blood Infections in Hemodialysis Patients Using Amoxicillin/Clavulanic Acid or Clindamycin

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Effectiveness of Moxifloxacin and Drug Combination for Treating Bone Implant Infections in Patients with Long Bone Fractures

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Study on the Effectiveness and Safety of Clindamycin and Tretinoin Gel for Patients with Papulopustular Acne

    Recruiting

    1 1 1
    Investigated drugs:
    Germany

  • Study on Early Oral Antibiotic Treatment for Vertebral Osteomyelitis Using Cefuroxime, Dicloxacillin, and Ceftriaxone for Adult Patients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study of Aztreonam-Avibactam and Metronidazole for Children with Serious Gram-Negative Bacterial Infections

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Greece Hungary Spain

  • Study Comparing Clindamycin to Rifampicin and Drug Combination for Patients with Prosthetic Joint Infection

    Recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands

Glossary

  • Bacterial Vaginosis (BV): A common vaginal infection caused by an imbalance of naturally occurring bacteria in the vagina.
  • Preterm Birth: The birth of a baby before 37 weeks of pregnancy are completed.
  • In Vitro Fertilization (IVF): A series of procedures in which an egg is fertilized by sperm outside of the body to help with pregnancy.
  • Septic Abortion: A serious infection of the placenta and fetus resulting from an abortion.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and excreted by the body.
  • Clinical Pregnancy Rate: The percentage of treatment cycles resulting in a pregnancy confirmed by ultrasound.
  • Placebo: A substance with no active therapeutic effect, used as a control in testing new drugs.
  • Body Mass Index (BMI): A measure that uses your height and weight to work out if your weight is healthy.
  • Empirical Bayesian Estimates (EBE): A statistical method used to estimate individual pharmacokinetic parameters.
  • Vaginal Microbiota: The community of microorganisms that live in the vagina.

References

  1. https://clinicaltrials.gov/study/NCT01500837
  2. https://clinicaltrials.gov/study/NCT02593383
  3. https://clinicaltrials.gov/study/NCT02348463
  4. https://clinicaltrials.gov/study/NCT03080740
  5. https://clinicaltrials.gov/study/NCT02309346
  6. https://clinicaltrials.gov/study/NCT01757236
  7. https://clinicaltrials.gov/study/NCT01744730
  8. https://clinicaltrials.gov/study/NCT00887484
  9. https://clinicaltrials.gov/study/NCT00642980